ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 111533 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 111533; 2) Community: the network communities that were significantly associated with the response to NSC 111533; 3) Molecule: the relationships between components within communities and NSC 111533; 4) MDR: the compounds that were significantly associated with the NSC 111533.

NSC Compound Enrichment Correlation
NSC 330507 Tanespimycin 0.0133299224082802 0.061381137
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0133299224082802 0.2490643
NSC 634353 5,6-Diazaspiro[2,4]hept-4-ene-1,1-dicarbonitrile, 4-methyl-7-oxo-2,6-diphenyl, trans-(+/-)- 0.0133299224082802 0.18318652
NSC 638636 Null 0.0133299224082802 0.039894347
NSC 650935 3,8-Dimethyl-1,2-naphthoquinone 0.0133299224082802 0.09464697
NSC 670312 Null 0.0133299224082802 0.12467424
NSC 670995 Null 0.0133299224082802 0.41663051
NSC 702137 Null 0.0133299224082802 0.22084408
NSC 354462 Hypothemycin 0.0135714101922723 -0.16982636
NSC 718781 Erlotinib hydrochloride 0.0135714101922724 -0.20998654
Total:56  Current:17    [First] [Prev] [Next] [Last]